Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C

Lignende værker

• Reply: Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C
  af: O’Brien, Thomas R., et al.
  Udgivet: (2015)
• Analysis of Subgroup Differences in the ION-3 Trial of Ledipasvir-Sofosbuvir in Chronic Hepatitis C Infection
  af: Kowdley, Kris V., et al.
  Udgivet: (2015)
• No Difference in Effectiveness of 8 vs 12 Weeks of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C in Black Patients
  af: Marcus, Julia L., et al.
  Udgivet: (2018)
• No Scientific Basis to Restrict 8 Weeks of Treatment with Ledipasvir/Sofosbuvir to Patients with HCV RNA <6,000,000 IU/ml
  af: O’Brien, Thomas R., et al.
  Udgivet: (2015)
• Treatment efficacy of ledipasvir/sofosbuvir for 8 weeks in non-cirrhotic chronic hepatitis C genotype 4 patients
  af: Mohammed A Babatin, et al.
  Udgivet: (2019-01-01)